Metagenomi Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 0.7803 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 29.48M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Metagenomi Therapeutics, Inc. an in vivo genome editing company, develops curative genetic medicines in the United States. The company’s lead development program, MGX-001, is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia. It has a collaboration agreement with Ionis Pharmaceuticals, Inc. for apolipoprotein C-III for the treatment of hyper triglyceridemia, transthyretin (TTR) for transthyretin amyloidosis, angiotensinogen (AGT) for refractory hypertension, and other programs. The company was formerly known as Metagenomi, Inc. and changed its name to Metagenomi Therapeutics, Inc. in January 2026. Metagenomi Therapeutics, Inc. was incorporated in 2016 and is headquartered in Emeryville, California.
Details
| Name | Metagenomi Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 113 |
| Founded | 2018 |
| Ipo Date | 2024-02-09 |
| Ceo | Jian Irish |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 15.00 |
| Isin | US59102M1045 |
| Cusip | 59102M104 |
| Cik | 1785279 |
| Sic | 2836 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Jian Irish M.B.A., Ph.D. | Chief Executive Officer, President and Director |
| Pamela M. Wapnick M.B.A. | Chief Financial Officer |
| Matthew L. Wein J.D. | General Counsel, Compliance Officer, Head of BD&L and Corporate Secretary |
| Dr. Joseph Knowles M.D. | Co-Founder and Member of Scientific Advisory Board |
| Mark Leonard | Senior Vice President of Technical Development and Operations |
| Dr. Alan Brooks Ph.D. | Senior Vice President of Research |
| Katalin Kauser M.D., Ph.D. | Senior Vice President of Translational Biology |
| Nikhil Bhide M.B.A. | Senior Vice President of Business Development |
Contact
| Address | 5959 Horton Street, 7th Floor, EmeryVille, California 94608, United States |
| Phone | 510 871 4880 |
| Website | https://metagenomi.co |